Stock Research: Personalis

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Personalis

NasdaqGM:PSNL US71535D1063
42
  • Value
    34
  • Growth
    76
  • Safety
    Safety
    23
  • Combined
    42
  • Sentiment
    60
  • 360° View
    360° View
    42
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and analytics to support personalized cancer vaccines and immunotherapies. Its main businesses include genomic sequencing and analytics, with products like NeXT Personal, ImmunoID NeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). The company's tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and personalized cancer therapies. In the last fiscal year, the company had a market cap of $563 million, profits of $27 million, revenue of $85 million, and 229 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 42 (better than 42% compared with alternatives), overall professional sentiment and financial characteristics for the stock Personalis are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Personalis. The consolidated Growth Rank has a good rank of 76, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 76% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 60, which means that professional investors are more optimistic about the stock than for 60% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 23, which means that the share price of Personalis is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 77% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 34, which means that the company has a financing structure that is riskier than those of 66% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
23 28 85 71
Growth
76 55 39 7
Safety
Safety
34 26 79 90
Sentiment
60 70 64 29
360° View
360° View
42 41 91 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
77 71 67 64
Opinions Change
50 36 50 50
Pro Holdings
n/a 51 41 19
Market Pulse
65 75 51 38
Sentiment
60 70 64 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
23 28 85 71
Growth
76 55 39 7
Safety Safety
34 26 79 90
Combined
42 14 82 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
88 88 88 30
Price vs. Earnings (P/E)
26 35 91 38
Price vs. Book (P/B)
32 43 88 94
Dividend Yield
1 1 1 1
Value
23 28 85 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
91 14 14 8
Profit Growth
37 73 56 26
Capital Growth
32 28 71 87
Stock Returns
84 100 35 7
Growth
76 55 39 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
69 62 68 100
Refinancing
50 47 89 99
Liquidity
4 1 7 1
Safety Safety
34 26 79 90

Similar Stocks

Discover high‑ranked alternatives to Personalis and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

PriceSmart

NasdaqGS:PSMT
Country: USA
Industry: Hypermarkets, Super Centers
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.